Principales conclusions et analyse des parts de marché des médicaments d'origine marine d'ici 2025-2031
Marine-derived Drugs Market Report Analysis
Marine-derived Drugs Market
-
CAGR (2025 - 2031)8.2% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Pfizer, Inc.
- Abbott
- GlaxoSmithKline PLC
- Aker BioMarine AS
- Pharma Mar S.A
- Eisai Co., Ltd.
- Aker BioMarine AS
- Sea Run Holdings, Inc.
- Aphios Corporation
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Type
- phénol
- stéroïde
- éther
- peptide
- autre
By Source
- algues
- invertébrés
- micro-organismes
By Mode d'administration
- antimicrobien
- antitumoral
- anticardiovasculaire
- antiviral
- anti-inflammatoire
- autres
By Utilisateurs finaux
- hôpitaux et cliniques
- pharmacies
- autres
Get Free Sample For